Effect of Nitrate Supplementation on Blood Pressure and Microvascular Function of Resistant Hypertensive Patients
Recruiting now · Early Phase 1 · Has a placebo group
Conditions studied: Arterial Hypertension, Resistant Hypertension, Microvascular Function, Nitrate Supplementation
In brief
Arterial hypertension (AH) has been identified as an important public health problem and considered a new epidemic with high mortality and morbidity. High blood pressure (BP) levels increase the chances of coronary artery disease (CAD), heart failure (HF), stroke, chronic renal failure (CRF) and death. Beetroot powder may be an easier way to increase the availability of nitric oxide and consequently vasodilation in these patients. However, studies are needed to evaluate its benefits in patients with AH.
Key facts
- Study ID
- NCT06169241
- Run by
- National Institute of Cardiology, Laranjeiras, Brazil
- People needed
- 50
- Starts
- 2023-11-01
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2026-04-13
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Resistant hypertension, with a diagnosis described in the medical record, without changing medications or increasing doses in the last 30 days.
You may not qualify if…
- neoplasms
- heart failure
- use of medications with nitrate in their formula
- patients undergoing renal denervation
Where it is running
- National Institute of Cardiology — Rio de Janeiro, Brazil (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.